세계의 분석 표준 물질 시장 : 기술별, 용도별, 분석법별, 카테고리별, 지역별 - 예측(-2030년)

The global analytical standards market is projected to reach USD 1.53 billion in 2024 to USD 2.16 billion by 2030, at a CAGR of 5.9% during the forecast period. The growing applications of analytical techniques in proteomics & metabolomics is one of the major factors anticipated to boost market growth in the forecasting years. Additionally, rising regulatory emphasis in pharmaceutical industry affects the growth of the analytical standards market.

"The contact-based analytical standards segment to hold the largest share of the market in 2024."

Based on category, analytical standards is segmented into organic standards and inorganic standards. The organic standards segment is expected to dominate the analytical standards market during the forecast period. With the rising number of clinical trials, the increasing focus on drug discovery & development, strict regulatory emphasis on effective pollution monitoring & control, and increasing public-private investments for R&D activities leads to the growth of this market segment.

"The external beam analytical standards procedures segment to hold the largest share of the market in 2024."

Based on technique, the analytical standards market is segmented into chromatography, spectroscopy, titrimetry, and physical properties testing. The analytical standards market is expected to be dominated by spectroscopy segment during the forecast period. The spectroscopy segment is further segmented into atomic absorption spectroscopy, mass spectroscopy, IR spectroscopy, nuclear magnetic resonance spectroscopy, UV/Vis spectroscopy and X-ray fluorescence/diffraction spectroscopy. The spectroscopy are expected to grow due to the widespread use of spectroscopic techniques across a broad range of application areas such as forensic, biotech, and material science and rising technological advancements for the improvement of sensitivity and resolution.

"The raw material testing segment to hold the largest share of the market in 2024."

The methodology market is segmented into raw material testing, bioanalytical testing, stability testing, dissolution testing, and other methodologies. Raw material testing accounted for the largest share of the global analytical standards market during the forecasted years. This can be attributed to the rising disease prevalence and the increase in commercialization of parenteral drugs.

"The market in the APAC region is expected to register highest growth rate for analytical standards in 2024."

The analytical standards market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for analytical standards was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing market penetration opportunities in emerging APAC countries led to the growth of the analytical standards market in this region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1- 49%, Tier 2- 31%, and Tier 3- 20%
• By Designation: Directors- 19%, C-level- 28%, and Others- 53%
• By Region: North America- 31%, Europe- 33%, Asia Pacific- 19%, Latin America- 10%, MEA- 7%

The prominent players in the Analytical standards market are Merck KGaA (Germany), Agilent Technologies, Inc. (US), Waters Corporation (US), LGC Limited (UK), PerkinElmer (US), Restek Corporation (US), SPEX CertiPrep (US), AccuStandard (US), Thermo Fisher Scientific, Inc. (US), Mallinckrodt (UK), The United States Pharmacopeial Convention (US), Cayman Chemical (US), RICCA Chemical Company (US) and GFS Chemicals, Inc. (US), among others.

Research Coverage

This report studies the analytical standards market based on technique, application, category, methodology, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (Stringent regulatory guidelines in pharmaceutical industry, Rising public concerns regarding food safety & quality, Increasing public-private investments in research, Growing applications of analytical techniques in proteomics & metabolomics, Rising regulatory emphasis on pollution control, Growth in pharmaceutical & biotechnology industries, Increasing adoption of analytical techniques in pesticide monitoring), restraints (Limited public awareness of pollution monitoring strategies in emerging economies, Stringent storage requirements for analytical standards), opportunities (Development of new drugs adhering to GMP regulations, Increasing number of clinical trials), and challenges (Inadequate standards for analytical techniques, Shortage of skilled laboratory technicians) influencing the growth of the analytical standards market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the analytical standards market
• Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and analytical developments in the analytical standards market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the analytical standards market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 REGIONS COVERED
  • 1.3.4 YEARS CONSIDERED
  • 1.3.5 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Objectives of primary research
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.1.1 Segmental revenue share analysis
  • 2.2.2 USAGE-BASED MARKET ESTIMATION
  • 2.2.3 TOP-DOWN APPROACH
  • 2.2.4 VOLUME DATA ANALYSIS
  • 2.2.5 PRIMARY RESEARCH VALIDATION
• 2.3 DATA TRIANGULATION
• 2.4 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ANALYTICAL STANDARDS MARKET OVERVIEW
• 4.2 EUROPE: ANALYTICAL STANDARDS MARKET, BY APPLICATION AND REGION (2023)
• 4.3 ANALYTICAL STANDARDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 ANALYTICAL STANDARDS MARKET: REGIONAL MIX, 2022-2030 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Stringent regulatory guidelines in pharmaceutical industry
    • 5.2.1.2 Rising public concerns regarding food safety & quality
    • 5.2.1.3 Increasing public-private investments in research
    • 5.2.1.4 Growing applications of analytical techniques in proteomics & metabolomics
    • 5.2.1.5 Rising regulatory emphasis on pollution control
    • 5.2.1.6 Growth in pharmaceutical & biotechnology industries
    • 5.2.1.7 Increasing adoption of analytical techniques in pesticide monitoring
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limited public awareness of pollution monitoring strategies in emerging economies
    • 5.2.2.2 Stringent storage requirements for analytical standards
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Development of new drugs adhering to GMP regulations
    • 5.2.3.2 Increasing number of clinical trials
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Inadequate standards for analytical techniques
    • 5.2.4.2 Shortage of skilled laboratory technicians
• 5.3 REGULATORY SCENARIO
  • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.3.2 REGULATORY FRAMEWORK
    • 5.3.2.1 North America
      • 5.3.2.1.1 US
      • 5.3.2.1.2 Canada
    • 5.3.2.2 Europe
    • 5.3.2.3 Asia Pacific
      • 5.3.2.3.1 China
      • 5.3.2.3.2 Japan
      • 5.3.2.3.3 India
    • 5.3.2.4 Latin America
      • 5.3.2.4.1 Brazil
      • 5.3.2.4.2 Mexico
    • 5.3.2.5 Middle East
    • 5.3.2.6 Africa
• 5.4 VALUE CHAIN ANALYSIS
  • 5.4.1 RESEARCH & DEVELOPMENT
  • 5.4.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
  • 5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.5 SUPPLY CHAIN ANALYSIS
  • 5.5.1 PROMINENT COMPANIES
  • 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.5.3 DISTRIBUTORS
  • 5.5.4 END USERS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7.2 BARGAINING POWER OF SUPPLIERS
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 THREAT OF SUBSTITUTES
  • 5.7.5 THREAT OF NEW ENTRANTS
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT DATA HS CODE 293499
  • 5.9.2 EXPORT DATA HS CODE 293499
• 5.10 PATENT ANALYSIS
  • 5.10.1 LIST OF MAJOR PATENTS
• 5.11 PRICING ANALYSIS
  • 5.11.1 AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY APPLICATION (2024)
  • 5.11.2 AVERAGE SELLING PRICE OF ANALYTICAL STANDARDS, BY KEY PLAYER (2024)
  • 5.11.3 AVERAGE SELLING PRICE TREND OF ANALYTICAL STANDARDS, BY REGION (2022-2024)
• 5.12 TECHNOLOGY ANALYSIS
  • 5.12.1 KEY TECHNOLOGIES
    • 5.12.1.1 Chromatography
    • 5.12.1.2 Spectroscopy
    • 5.12.1.3 Physical property testing
    • 5.12.1.4 Titration
  • 5.12.2 COMPLEMENTARY TECHNOLOGIES
    • 5.12.2.1 Data analysis technologies
    • 5.12.2.2 Imaging & microscopy technologies
    • 5.12.2.3 Automation & control systems
  • 5.12.3 ADJACENT TECHNOLOGIES
    • 5.12.3.1 Molecular diagnostics
    • 5.12.3.2 Process Analytical Technology (PAT)
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 UNMET NEEDS
• 5.17 IMPACT OF AI/GENERATIVE AI ON ANALYTICAL STANDARDS MARKET

6 ANALYTICAL STANDARDS MARKET, BY TECHNIQUE

• 6.1 INTRODUCTION
• 6.2 SPECTROSCOPY
  • 6.2.1 MASS SPECTROSCOPY
    • 6.2.1.1 Increasing research focus on multiple molecules and specific metabolites to drive market
  • 6.2.2 ATOMIC ABSORPTION SPECTROSCOPY
    • 6.2.2.1 High-throughput capabilities to fuel uptake
  • 6.2.3 UV/VISIBLE SPECTROSCOPY
    • 6.2.3.1 Rapid analytical responses and ease of use to drive market
  • 6.2.4 X-RAY FLUORESCENCE/DIFFRACTION SPECTROSCOPY
    • 6.2.4.1 Low cost of sample preparation to support market growth
  • 6.2.5 IR SPECTROSCOPY
    • 6.2.5.1 High adoption among researchers & scientists to fuel market
  • 6.2.6 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
    • 6.2.6.1 Advantages of high speed & accuracy to boost demand
  • 6.2.7 OTHER SPECTROSCOPY STANDARDS
• 6.3 CHROMATOGRAPHY
  • 6.3.1 ION CHROMATOGRAPHY
    • 6.3.1.1 Multiple ion analysis for organic acids & anions to drive market
  • 6.3.2 GAS CHROMATOGRAPHY
    • 6.3.2.1 High stability & sensitivity features to fuel uptake
  • 6.3.3 LIQUID CHROMATOGRAPHY
    • 6.3.3.1 High automation and versatility to support market growth
  • 6.3.4 THIN-LAYER CHROMATOGRAPHY
    • 6.3.4.1 Rapid analysis time and low solvent consumption to support market growth
  • 6.3.5 OTHER CHROMATOGRAPHY STANDARDS
• 6.4 TITRIMETRY
  • 6.4.1 UTILIZATION IN QUANTITATIVE CHEMICAL ANALYSIS FOR PHARMACEUTICAL APPLICATIONS TO PROPEL MARKET
• 6.5 PHYSICAL PROPERTY TESTING
  • 6.5.1 VISCOSITY TESTING
    • 6.5.1.1 Stringent regulations for assessing F&B testing quality to drive market
  • 6.5.2 SIEVE CALIBRATION & PARTICLE SIZE TESTING
    • 6.5.2.1 Increasing research activities in nanotechnology to fuel market
  • 6.5.3 COLOR REFERENCE TESTING
    • 6.5.3.1 Rising production of petrochemical products to support market growth
  • 6.5.4 OTHER PHYSICAL PROPERTY TESTING STANDARDS

7 ANALYTICAL STANDARDS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 PHARMACEUTICAL & LIFE SCIENCE STANDARDS
  • 7.2.1 PHARMACOPOEIA STANDARDS
    • 7.2.1.1 Presence of stringent regulations for drug approval processes to fuel market
  • 7.2.2 PHARMACEUTICAL IMPURITY REFERENCE STANDARDS
    • 7.2.2.1 Ability to analyze, identify, and quantify drug impurities to drive market
  • 7.2.3 PHARMACEUTICAL SECONDARY STANDARDS
    • 7.2.3.1 Growing need for high-quality raw materials to drive market
  • 7.2.4 HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS
    • 7.2.4.1 Detection of contaminants to fuel uptake
  • 7.2.5 COSMETIC STANDARDS
    • 7.2.5.1 Identification of hazardous ingredients in cosmetic products to boost demand
  • 7.2.6 FLUORESCENT MICROPARTICLE STANDARDS
    • 7.2.6.1 Broadening applications of flow cytometry and elemental analysis to fuel uptake
• 7.3 FOOD & BEVERAGE STANDARDS
  • 7.3.1 PEPTIDE/AMINO ACID STANDARDS
    • 7.3.1.1 Determination of amino acid concentration & proteins to fuel uptake
  • 7.3.2 FLAVOR & FRAGRANCE STANDARDS
    • 7.3.2.1 Growing need for enhanced trace-level detection to drive market
  • 7.3.3 MYCOTOXIN STANDARDS
    • 7.3.3.1 Stringent regulations regarding mycotoxin concentration in edibles to drive market
  • 7.3.4 CARBOHYDRATE STANDARDS
    • 7.3.4.1 Increasing regulations for food safety & labeling to support market growth
  • 7.3.5 FATTY ACID/LIPID STANDARDS
    • 7.3.5.1 Qualitative & quantitative Identification of fatty acids to boost demand
  • 7.3.6 FOOD ADDITIVE STANDARDS
    • 7.3.6.1 Rising need for food additive detection to propel market
  • 7.3.7 PESTICIDE STANDARDS
    • 7.3.7.1 Growth in organic & sustainable farming to drive segment
  • 7.3.8 GMO STANDARDS
    • 7.3.8.1 Rising focus on genetic engineering activities to fuel market
  • 7.3.9 OTHER FOOD & BEVERAGE STANDARDS
• 7.4 FORENSIC STANDARDS
  • 7.4.1 DRUGS-OF-ABUSE STANDARDS
    • 7.4.1.1 Detection of illegal drugs using chromatography & spectrometry techniques to fuel uptake
  • 7.4.2 DOPING STANDARDS
    • 7.4.2.1 Stringent anti-doping regulations to fuel market
  • 7.4.3 OTHER FORENSIC STANDARDS
• 7.5 VETERINARY DRUG STANDARDS
  • 7.5.1 ANTIBIOTIC STANDARDS
    • 7.5.1.1 Analysis of antibiotics in animal food products with LC & MC techniques to boost demand
  • 7.5.2 HORMONE STANDARDS
    • 7.5.2.1 Growing consumer awareness regarding harmful veterinary hormones in food items to drive market
• 7.6 PETROCHEMICAL STANDARDS
  • 7.6.1 GASOLINE, DIESEL, AND PETROLEUM STANDARDS
    • 7.6.1.1 Rising need to curb air pollution to fuel uptake
  • 7.6.2 BIOFUEL STANDARDS
    • 7.6.2.1 Increasing focus on biofuel research to support market growth
• 7.7 ENVIRONMENTAL STANDARDS
  • 7.7.1 PESTICIDE STANDARDS
    • 7.7.1.1 Detection of pesticides in drinking water and soil samples through LC-MS to fuel uptake
  • 7.7.2 PFAS TESTING STANDARDS
    • 7.7.2.1 Rising public health concerns for PFAS contamination to drive market
  • 7.7.3 MICROPLASTIC TESTING STANDARDS
    • 7.7.3.1 Increasing concerns & growing awareness associated with microplastic contamination to support market growth
  • 7.7.4 VOLATILE STANDARDS
    • 7.7.4.1 Rising use in analytical labs for volatile compound quantification to support market growth
  • 7.7.5 SEMI-VOLATILE STANDARDS
    • 7.7.5.1 Mandatory semi-volatile testing for air pollutants to drive market
  • 7.7.6 AROCLOR/PCB AND DIOXIN STANDARDS
    • 7.7.6.1 High environmental contamination of toxic industrial chemicals to fuel uptake
  • 7.7.7 FLAME-RETARDANT STANDARDS
    • 7.7.7.1 Growing focus on flame-retardant analysis in soil & wastewater to drive segment
  • 7.7.8 OTHER ENVIRONMENTAL STANDARDS
• 7.8 CLINICAL DIAGNOSTICS STANDARDS
  • 7.8.1 HORMONE TESTING STANDARDS
    • 7.8.1.1 High production costs to restrict segment growth
  • 7.8.2 VITAMIN STANDARDS
    • 7.8.2.1 Rising demand for nutritional evaluation to drive market
  • 7.8.3 BIOMARKER STANDARDS
    • 7.8.3.1 Increasing focus on R&D activities for cancer and neurodegenerative disease to fuel market
  • 7.8.4 CLINICAL TOXICOLOGY STANDARDS
    • 7.8.4.1 Rising cases of drug toxicity to fuel uptake
  • 7.8.5 OTHER CLINICAL DIAGNOSTICS STANDARDS

8 ANALYTICAL STANDARDS MARKET, BY METHODOLOGY

• 8.1 INTRODUCTION
• 8.2 RAW MATERIAL TESTING
  • 8.2.1 RISING MANUFACTURING OF MEDICINAL & PETROCHEMICAL PRODUCTS TO DRIVE MARKET
• 8.3 STABILITY TESTING
  • 8.3.1 INCREASING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET
• 8.4 BIOANALYTICAL TESTING
  • 8.4.1 GROWING FOCUS ON TESTING OF BIOLOGICS & BIOSIMILARS TO FUEL UPTAKE
• 8.5 DISSOLUTION TESTING
  • 8.5.1 INCREASING PUBLIC-PRIVATE INVESTMENTS IN RESEARCH TO SUPPORT MARKET GROWTH
• 8.6 OTHER METHODOLOGIES

9 ANALYTICAL STANDARDS MARKET, BY CATEGORY

• 9.1 INTRODUCTION
• 9.2 ORGANIC STANDARDS
  • 9.2.1 INCREASING FOCUS ON DRUG DEVELOPMENT AND CLINICAL TRIALS TO PROPEL MARKET
• 9.3 INORGANIC STANDARDS
  • 9.3.1 INCREASING GOVERNMENT REGULATIONS ON PESTICIDE MONITORING & SOIL TESTING TO SUPPORT MARKET GROWTH

10 ANALYTICAL STANDARDS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Availability of public-private investments for life sciences research to fuel market
  • 10.2.3 CANADA
    • 10.2.3.1 Availability of government funding for research & innovation to drive market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Growing focus on bioclusters and expansion of biotechnology sector to propel market
  • 10.3.3 UK
    • 10.3.3.1 Utilization of analytical techniques in food testing to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Established biotech hub to fuel uptake
  • 10.3.5 ITALY
    • 10.3.5.1 Growing focus on development of innovative molecules & therapies to boost demand
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising demand for import of pharmaceutical products to fuel markets
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Increasing utilization of advanced analytical technologies to propel market
  • 10.4.3 CHINA
    • 10.4.3.1 Rising incidence of infectious diseases and growing focus on stringent pharma guidelines to boost demand
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing demand for soil & water testing to fuel market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Rising focus on proteomics & metabolomics research to support market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Broadening applications for science research to propel market
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Application of electrophoresis techniques in target disease treatments to fuel uptake
  • 10.5.3 MEXICO
    • 10.5.3.1 Public-private investments in the country's healthcare system to support market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Adoption of economic diversification strategies to drive market
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANALYTICAL STANDARDS MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.4.1 ORGANIC ANALYTICAL STANDARDS MARKET RANKING
  • 11.4.2 INORGANIC ANALYTICAL STANDARDS MARKET RANKING
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Technique footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 Methodology footprint
    • 11.5.5.6 Category footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key emerging players/startups
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 COMPANY VALUATION
  • 11.7.2 FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 MERCK KGAA
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 THE UNITED STATES PHARMACOPEIAL CONVENTION
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Key strengths
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 LGC LIMITED
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 AGILENT TECHNOLOGIES, INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
      • 12.1.4.3.2 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 WATERS CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 THERMO FISHER SCIENTIFIC INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Expansions
  • 12.1.7 MALLINCKRODT
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 PERKINELMER
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 RESTEK CORPORATION
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
  • 12.1.10 SPEX CERTIPREP
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 ACCUSTANDARD
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
  • 12.1.12 CAYMAN CHEMICAL
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 RICCA CHEMICAL COMPANY
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 GFS CHEMICALS, INC.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Deals
  • 12.1.15 CHIRON AS (PART OF ANTYLIA SCIENTIFIC)
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches
      • 12.1.15.3.2 Expansions
• 12.2 OTHER PLAYERS
  • 12.2.1 CAMBRIDGE ISOTOPE LABORATORIES, INC.
  • 12.2.2 REAGECON DIAGNOSTICS LTD.
  • 12.2.3 CPI INTERNATIONAL
  • 12.2.4 CRESCENT CHEMICAL CO., INC.
  • 12.2.5 INORGANIC VENTURES
  • 12.2.6 ALFA CHEMISTRY
  • 12.2.7 BIOSYNTH
  • 12.2.8 HPC STANDARDS GMBH
  • 12.2.9 TOKYO CHEMICAL INDUSTRY CO., LTD.
  • 12.2.10 SIMSON PHARMA LIMITED
  • 12.2.11 NOVACHEM
  • 12.2.12 LABSERT
  • 12.2.13 WELLINGTON LABORATORIES INC.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS